There are two widely used definitions of exacerbation. The Anthonisen definition is based on the presence of one or more of three cardinal symptoms, including. La enfermedad pulmonar obstructiva crónica (EPOC) es una entidad que causa una gran 9. eisner md, Anthonisen n, coultas d, et al. 38 | Proceso asistencial integrado del paciente con EPOC exacerbado. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA.

Author: Samule Vobar
Country: Burma
Language: English (Spanish)
Genre: Career
Published (Last): 17 March 2005
Pages: 358
PDF File Size: 5.93 Mb
ePub File Size: 1.95 Mb
ISBN: 978-5-93541-536-5
Downloads: 26370
Price: Free* [*Free Regsitration Required]
Uploader: Mezimuro

Therefore, in this sub-group of patients, a sputum or tracheobronchial aspirate if intubated culture should be obtained to allow adjustment of antibiotics based on the in vitro susceptibility of pathogens isolated. Formos Med Assoc, 91pp.

There was a problem providing the content you requested

Nocturnal deaths among patients with chronic bronchitis and enphysema. Microbial pathogens in COPD exacerbations The list of potential pathogens in COPD exacerbations includes typical respiratory bacterial pathogens, respiratory viruses and atypical bacteria Table 2.

The benefit of antibiotics in mild exacerbations is unproven and warrants a anthonsen controlled trial. However, because of antigenic variability among strains of these bacterial species, the antibodies that develop to the infecting strain are usually strain-specific, and do not provide protection to the host from other antigenically distinct strains of the same species.

Needs baseline assessment prior to exacerbation onset for comparison.

Chest, 97pp. However, it appears to be similar to bacterial infections. Recently, comparison trials with nontraditional end-points have shown differences among antibiotics in the treatment of exacerbations of COPD. If symptoms do indeed correlate with exaggerated airway and systemic inflammation, then acceptance of clinical improvement rather than clinical resolution has important implications.


Corresponding clinical manifestations are dyspnea, cough, increased sputum production, tenacity and purulence along with worsening gas exchange, which are the cardinal manifestations of an exacerbation. A prospective study anthonisn patients.

Optimizing antibiotic selection in treating COPD exacerbations

Our understanding of the etiology, pathogenesis and consequences of acute exacerbations of chronic obstructive pulmonary disease COPD has increased substantially in the last decade. These three pathogens are all exclusively human pathogens that are transmitted among individuals. End of therapy and long-term anthoniseh assessments were made at the conventional 10—14 day and 28 day time intervals. A unique feature of this study was anrhonisen measurement of primary outcome at 5 days, instead of the traditional 2—3 weeks.

Optimizing antibiotic selection in treating COPD exacerbations

J Chronic Obstructive Pul Dis3: Global Initiative for Obstructive Lung Disease. However, desaturation episodes must be detected in patients with COPD and sleep apnea-hypopnea syndrome SAHSsince morbidity and mortality are higher when these two entities are combined than when they occur separately. In many instances, the adaptive immune response results in development of mucosal and systemic antibodies to the pathogen Sethi et al ; Murphy et al This has been shown in mild disease, in the Lung Health Study, where every lower respiratory tract illness was associated with an additional loss of 7 ml of FEV 1 Kanner et al New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease.

Isolated in very severe COPD, concomitant bronchiectasis, recurrent exacerbations.

However, emerged resistance among P aeruginosa to the fluoroquinolones may compromise their efficacy. Another limitation is the lack of gradation of severity within each symptom, such that an exacerbation with mild dyspnea and mild increase in sputum would be regarded as the same severity in this classification as one with a marked increase in both symptoms. Pathogenesis of exacerbations The emerging concept that an increase in airway inflammation from the baseline level epov of COPD is central to the pathogenesis of acute exacerbations is supported by several recent studies White et al ; Sethi a.


Exposure to antibiotic is not confined to those prescribed for respiratory infections, but includes antibiotics prescribed for any indication. The pathogenesis of acute viral exacerbations is less well understood.

Persistence of systemic inflammation predicts early relapse.

EPOC y apneas del sueño | Archivos de Bronconeumología

Poor penetration of antibiotics used in to respiratory tissues. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO 2 above 60 mmHg.

In a recent study by Hurst et al of 36 plasma biomarkers antyonisen 90 patients with exacerbations, none of them alone or in combination were adequate to define an exacerbation Hurst et al Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long term oxygen therapy. It is evident that we need a better definition and objective measures of severity of exacerbations.

You can change the settings or obtain more information by clicking here.

Lengthening the inter-exacerbation interval and prevention of early relapse are being increasingly recognized as important clinical goals of treatment, because they ultimately translate to a decrease in the frequency of exacerbations, which is now a major focus of COPD treatment. Introduction Anghonisen obstructive pulmonary disease COPD is the fourth leading cause of death in the United States and the 6th leading cause worldwide.

Proc Am Thorac Soc, 5pp. Curr Opin Infect Dis.